Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer

Sponsor
University of Chile (Other)
Overall Status
Completed
CT.gov ID
NCT00935779
Collaborator
(none)
18
1
26
0.7

Study Details

Study Description

Brief Summary

Peritoneal metastases appear in a great proportion of patients affected by gastric carcinoma. Involved mechanisms are poorly understood though experimentally it has been demonstrated that neoplastic cells exfoliated from primary tumor can only implant and proliferate in areas of damaged peritoneum. Objectives: to study ultra-structure of peritoneal surface by electronic microscopy in control subjects and in patients with early or locally advanced gastric cancer looking for spontaneous changes in peritoneal surface not related with surgical injury.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    18 out of 32 cases were eligible for analysis. Four patients operated on for benign diseases served as control and 14 patients with operable local gastric adenocarcinoma (4 mucosa/submucosa/muscular y 10 serosa lesions) were studied. At the beginning of surgery, a 2 x 2 cm. sample from macroscopically normal visceral peritoneum at mesenterium root was carefully obtained, washed with saline and fixed in glutaraldehyde solution. Besides a sample of peritoneal washing fluid was studied to exclude patients with free cancer cells. Peritoneal tissue was fixed during 24 hours and then all samples were evaluated by electronic microscope.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    18 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Ultra Structure of Peritoneum at Electronic Microscopy in Control Subjects and Patients With Gastric Cancer
    Study Start Date :
    Oct 1, 2002
    Actual Primary Completion Date :
    Jul 1, 2004
    Actual Study Completion Date :
    Dec 1, 2004

    Arms and Interventions

    Arm Intervention/Treatment
    Gastric cancer

    patients with operable local gastric adenocarcinoma were studied

    Control group

    patients operated on for benign diseases served as controls, randomly selected among patients with chronic gastro-esophageal reflux disease who were considered good candidates for antireflux surgery and properly matched in sex and age to study group

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • patients with operable local gastric adenocarcinoma
      Exclusion Criteria:
      • previous abdominal surgery

      • previous open or blunt abdominal trauma

      • history of inflammatory bowel disease or Typhoid Fever, Gallstone disease, chemotherapy or radiotherapy, or any other abdominal condition that could alter peritoneal integrity.

      • All other gastric malignancies such as lymphomas, GIST, carcinoids

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Department of Surgery, Clinical Hospital, University of Chile Santiago Region Metropolitana Chile

      Sponsors and Collaborators

      • University of Chile

      Investigators

      • Principal Investigator: Patricio Burdiles, MD, Department of Surgery, Clinical Hospital, University of Chile

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00935779
      Other Study ID Numbers:
      • OAIC 043/02
      First Posted:
      Jul 9, 2009
      Last Update Posted:
      Jul 9, 2009
      Last Verified:
      Jul 1, 2009
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Jul 9, 2009